Large Cardiovascular Disease Base
BRICS countries, including Brazil, Russia, India, China, and South Africa, have a large and growing base of patients suffering from cardiovascular diseases. Rapid urbanization, lifestyle changes, tobacco use, and increasing cases of hypertension and diabetes are contributing to a high burden of heart conditions across these nations. Many patients are diagnosed at advanced stages, which increases the risk of serious rhythm disorders and sudden cardiac arrest. This large patient population creates strong demand for long-term cardiac rhythm management solutions such as implantable cardioverter defibrillators (ICDs).
Healthcare systems across BRICS are expanding their focus on non-communicable diseases. Major urban hospitals in countries such as China, India, and Brazil are strengthening their cardiology and electrophysiology departments. Awareness among physicians regarding sudden cardiac death prevention is improving, and international treatment guidelines are followed in tertiary care centers. As more high-risk patients are identified, the need for ICD therapy continues to grow.
Although access to advanced cardiac care still varies between urban and rural areas, leading cities across BRICS countries are well equipped to perform ICD implantation procedures. The large and expanding cardiovascular disease base acts as a strong driver for the ICD market in these emerging economies.
Expanding Reimbursement Access
Reimbursement access for ICD therapy across BRICS countries is gradually expanding, creating meaningful opportunities for market growth. Governments in these nations are investing in healthcare reforms and strengthening public insurance schemes to improve access to advanced treatments. In countries such as China and Brazil, national or social health insurance programs cover cardiac procedures performed in approved hospitals, supporting patient access to ICD implants.
Private healthcare and insurance coverage are also growing in several BRICS markets. In India, Brazil, and South Africa, private hospitals are crucial in offering advanced cardiac care. As middle-income populations expand and private insurance coverage increases, more patients gain access to specialized device therapies. This trend encourages hospitals to invest in modern cardiac technologies and trained specialists.
While reimbursement frameworks are developing in some regions, policymakers are recognizing the importance of reducing deaths from serious heart conditions. Efforts to improve healthcare funding and expand insurance coverage for life-saving treatments are ongoing. As reimbursement access continues to broaden across BRICS countries, it presents a significant opportunity for ICD manufacturers to strengthen their presence and improve patient access to advanced cardiac rhythm management solutions.
